Medication info

Jungwoo 5-FU Injection (Fluorouracil)

Prescription medicationIntravenous injection
Ingredient · strength
Fluorouracil›50mg / 1mL
Manufacturer / importer
JW Pharmaceutical Corporation
Appearance
A transparent injection solution that is colorless to light yellow, contained in a brown ampule or vial
Packaging
5 milliliters, 10 milliliters, 20 milliliters
Approval status
Active

MFDS item code 197600064 · Notified 1976.04.14 · Insurance code 644902301,644902311,644902321

Summary

Main use
Carcinomas (e.g., colon cancer), carcinomas treated in combination (e.g., esophageal cancer), relief of symptoms of cutaneous malignancies
Who receives it
Adults
Adult administration
(Injection) 1. Intravenous injection (systemic administration): As monotherapy, the usual adult dose is 5~15 mg of fluorouracil per kg of body weight daily (not exceeding 1g per infusion), dissolved in 300~500 mL of 5% dextrose injection, administered by intravenous infusion daily for 5 days. Thereafter, administer 5~7.5 mg/kg by intravenous infusion every other day. Discontinue administration if adverse reactions occur. 2. Intra-arterial injection: As monotherapy, the usual adult dose is 5~7.5 mg/kg of this drug daily, dissolved in 20~100 mL of 5% dextrose injection and continuously infused using an infusion pump for 10~20 days. 3. In combination with radiation therapy: The usual adult dose is 5~10 mg/kg of this drug daily, administered in combination with radiation therapy according to the regimen for monotherapy. 4. In combination with other antineoplastic agents: The usual adult dose is 5~10 mg/kg of this drug daily, administered in combination with other antineoplastic agents according to the monotherapy regimen or intermittently 1~2 times per week. (Cream) Apply an appropriate amount of this drug to the affected area 1~2 times daily. In principle, occlusive dressing is preferable.

Ingredients

Manufacturer
JW Pharmaceutical Corporation

Efficacy & effects

Carcinomas (e.g., colon cancer), carcinomas treated in combination (e.g., esophageal cancer), relief of symptoms of cutaneous malignancies

  • Colon cancer
  • rectal cancer
  • breast cancer
  • stomach cancer
  • liver cancer
  • pancreatic cancer
  • ovarian cancer
  • uterine cancer
  • esophageal cancer
  • lung cancer
  • malignancies
  • tongue cancer
View approved original text

Used to relieve subjective and objective symptoms that patients experience in various types of cancer such as colon cancer, rectal cancer, breast cancer, stomach cancer, liver cancer, pancreatic cancer, ovarian cancer, and uterine cancer when administered as an injection. It is also used in combination with other anticancer agents or radiation therapy to enhance effectiveness for esophageal cancer, lung cancer, malignancies, and tongue cancer. When applied as a cream, it is effective for skin malignancies such as squamous cell carcinoma, basal cell carcinoma, Bowen's disease, Paget's disease, radiation keratosis, and senile keratosis.

How it is given

Adult administration

(Injection) 1. Intravenous injection (systemic administration): As monotherapy, the usual adult dose is 5~15 mg of fluorouracil per kg of body weight daily (not exceeding 1g per infusion), dissolved in 300~500 mL of 5% dextrose injection, administered by intravenous infusion daily for 5 days. Thereafter, administer 5~7.5 mg/kg by intravenous infusion every other day. Discontinue administration if adverse reactions occur. 2. Intra-arterial injection: As monotherapy, the usual adult dose is 5~7.5 mg/kg of this drug daily, dissolved in 20~100 mL of 5% dextrose injection and continuously infused using an infusion pump for 10~20 days. 3. In combination with radiation therapy: The usual adult dose is 5~10 mg/kg of this drug daily, administered in combination with radiation therapy according to the regimen for monotherapy. 4. In combination with other antineoplastic agents: The usual adult dose is 5~10 mg/kg of this drug daily, administered in combination with other antineoplastic agents according to the monotherapy regimen or intermittently 1~2 times per week. (Cream) Apply an appropriate amount of this drug to the affected area 1~2 times daily. In principle, occlusive dressing is preferable.

Precautions

This medication should be handled with extreme care when opening the ampule as glass fragments may be mixed in, especially for children and the elderly. Do not use this medication in combination with certain antiviral drugs as it may cause severe blood abnormalities. Patients should be under strict medical supervision during administration and should only be used in medical facilities equipped for emergencies with experienced staff. Regular liver function tests should be conducted as liver function may be affected; if symptoms such as loss of appetite or fatigue indicative of liver dysfunction occur, administration should be stopped immediately and treatment sought. May cause severe blood abnormalities if used with certain combination drugs, thus it should not be administered with them. Women who are pregnant or may become pregnant, nursing mothers, patients taking certain medications, and those with severe bone marrow suppression should not use this drug. Patients who are malnourished or have liver, kidney, or heart diseases, as well as the elderly and children should be especially cautious while using this medication and carefully monitored for adverse reactions. This medication may cause various side effects such as neurological symptoms, gastrointestinal disturbances, blood abnormalities, liver and kidney dysfunction, and skin or eye-related reactions; thus, symptoms should be carefully monitored and addressed immediately if abnormalities occur. Severe side effects such as bone marrow suppression and severe diarrhea may occur; regular blood tests and liver and kidney function tests should be performed, and if abnormal findings are confirmed, adjustments in dosage or cessation of administration should be considered. This medication may interact with other medications, exacerbating effects or side effects; therefore, inform your doctor or pharmacist of any concurrent medications. Pregnant or nursing women are advised not to use this medication, and women who could become pregnant must confirm their pregnancy status before administration. Children and elderly patients may experience more severe side effects from this medication, requiring closer observation and management during use. Overdosage may result in symptoms such as dizziness, movement disorders, speech difficulties, and Parkinsonism; report any such symptoms to medical staff immediately. There may be skin damage or inflammation at the injection site, so care should be taken regarding injection methods and sites, particularly with arterial administration, as severe skin or organ damage may occur. When using this drug, it is advisable to slow the injection speed to prevent venous inflammation or pain. This medication may be sensitive to ultraviolet light; therefore, it should be stored in a light-blocking container and exposure to sunlight should be avoided during and after topical application. If severe pain occurs at the application site, corticosteroid ointment may be used or application should be stopped, and skin reactions such as hair loss, rashes, and itching should be closely monitored. This medication should not be used directly on mucous membranes such as the eyes, nose, or mouth, and hands should be washed thoroughly after applying. It is recommended to check for the deficiency of the enzyme that degrades fluorouracil, dihydropyrimidine dehydrogenase (DPD), before using this drug, as toxicity risk increases with deficiency and dosage adjustments or cessation of administration may be needed. During administration, the cardiovascular and neurological symptoms should be regularly monitored; if abnormal symptoms arise, administration should be stopped immediately, and appropriate treatment obtained.

Side effects

Extrapyramidal symptoms, facial paralysis, speech disorders, ataxia, tremors, consciousness disorders, seizures, directional sense disorders, limb numbness, hallucinations, memory impairment, decreased spontaneity, incontinence, leukoencephalopathy, Parkinson's symptoms, fatigue, dizziness, posterior leukoencephalopathy syndrome, Wernicke's encephalopathy, appetite loss, nausea, vomiting, diarrhea, altered taste, polydipsia, abdominal distension, abdominal pain, rectal bleeding, constipation, angular cheilitis, glossitis, severe enteritis, gastrointestinal ulcers, severe stomatitis, acute pancreatitis, intestinal emphysema, enterocolitis, colitis, lactic acidosis, tumor lysis syndrome, hypertriglyceridemia, vitamin B1 deficiency, congestive heart failure, myocardial infarction, stable angina, pain, abnormal ECG, chest pain, chest discomfort, stress cardiomyopathy, pancytopenia, leukopenia, neutropenia, anemia, thrombocytopenia, hyperammonemia, hepatitis, liver dysfunction, jaundice, liver failure, acute renal failure, renal dysfunction, proteinuria, olfactory disorders, loss of smell, shock, anaphylaxis symptoms, rash, shortness of breath, hypotension, interstitial pneumonia, fulminant hepatitis, liver cirrhosis, ventricular tachycardia, nephrotic syndrome, skin and mucous membrane syndrome, toxic epidermal necrolysis, hemolytic anemia, hepatic artery intrahepatic biliary disorder, hand-foot syndrome, pigmentation, hair loss, edema, excoriation, vesicles, pruritus, erythema, nail abnormalities, phototoxic reactions, erythematous lupus, conjunctivitis, tearing, rash, arterial wall degeneration, thrombosis, fever, headache, diabetes, hypocalcemia, impaired glucose tolerance, localized reaction to extravascular leakage, pneumonia, sepsis, severe pain, alopecia, effervescence, vesicular pemphigoid, discomfort, ichthyosis, scales, purulence, swelling, capillary dilation, tenderness, urticaria, photosensitivity, nail discoloration, erythema, localized bleeding, dermatitis, nail deformity, emotional instability, insomnia, hypersensitivity reactions, stomatitis, unpleasant taste, eosinophilia, thrombocytopenia, toxic granulation, conjunctival response, corneal response, nasal irritation, herpes simplex

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a light-resistant, tightly sealed container at room temperature between 1°C and 30°C. This storage condition helps maintain the drug’s efficacy and safety.

Appearance and packaging

Appearance

A transparent injection solution that is colorless to light yellow, contained in a brown ampule or vial

Package unit

5 milliliters, 10 milliliters, 20 milliliters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.